IP Library Granted Patent US 12,496,469
Granted Patent B2
US 12,496,469 · App. 17/406,822 · Granted Dec 16, 2025

Devices and methods for endoluminal delivery of either fluid or energy for denervation

Inventors: Michi E. Garrison (Sunnyvale, CA); Richard M. Ruedy (Sunnyvale, CA)
Assignee: BOSTON SCIENTIFIC SCIMED, INC.
A61N7/00A61B17/3478A61B18/1492A61N7/022A61B2017/22054A61B2017/22067A61B2017/22082A61B2018/00291A61B2018/00404A61B2018/00434A61B2018/00511A61B2018/00577A61B2218/002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,496,469
App. No.
17/406,822
Granted
Dec 16, 2025
Kind
B2
Abstract

Described herein are methods and devices for selectively applying either fluids (e.g., anesthetics, nerve-blockers, etc.) or energy, such as radiofrequency or ultrasound energy, to a target tissue from within a blood vessel while minimizing the amount of fluid or energy applied to non-target tissue. The catheters described herein may include an elongate body, a directional injector, and one or more holdfasts for securing the catheter. In addition, catheters can include energy applying features for delivering energy to the target tissue.

Claims (37)

1 . A catheter device, comprising:

an elongate body having a distal end and a proximal end;

a passageway extending along a part of the elongate body, the passageway including an opening positioned adjacent the distal end and along an outer wall of the elongate body; and

an injector slidably engaged with the passageway and configured to extend through the opening and penetrate tissue of a carotid artery;

an ejectable holdfast including a plurality of flexible extensions, the plurality of flexible extensions expanding and extending from the distal end of the elongate body when ejected from the distal end of the elongate body, each flexible extension of the plurality of flexible extensions comprising a single length of flexible material that extends between a distal extension end and a proximal extension end, the proximal extension end being coupled to the elongate body, the plurality of flexible extensions radially expand and allow each distal extension end to contact inner walls of a carotid artery when the plurality of flexible extensions are ejected and extending from the distal end of the elongate body; and

wherein the plurality of flexible extensions all have distal ends that are disposed distally of the distal end of the elongate body when the plurality of flexible extensions are ejected from the distal end of the elongate body.

2 . The catheter device of claim 1 , wherein each flexible extension of the plurality of flexible extensions includes a coating, the coating including a rubber material or a silicone material.

3 . The catheter device of claim 1 , wherein the injector includes a fluid pathway for delivering a fluid to a target area.

4 . The catheter device of claim 3 , wherein the fluid includes one or more of an anesthetic, a nerve-blocker, a drug, and a therapeutic.

5 . The catheter device of claim 3 , wherein the target area includes extraluminal space or tissue adjacent a carotid artery.

6 . The catheter device of claim 1 , wherein the injector includes a fluid dispensing feature that controls a direction the fluid is dispensed.

7 . The catheter device of claim 1 , wherein the elongate body includes an outer diameter that is sized to allow the elongate body to travel along a carotid artery.

8 . The catheter device of claim 1 , wherein the elongate body has a length suitable for treatment of a carotid body via a transcervical approach.

9 . The catheter device of claim 8 , wherein the length of the elongate body is within a range of approximately 40 centimeters to 80 centimeters.

10 . A method, comprising:

inserting at least a part of a catheter device into a vessel body, wherein the catheter device includes an elongate body having a distal end and a proximal end, the catheter device including a passageway extending along a part of the elongate body, the passageway including an opening positioned adjacent the distal end and along an outer wall of the elongate body, the catheter device including an injector slidably engaged with the passageway and configured to extend through the opening and penetrate tissue of a carotid artery, the catheter device including an ejectable holdfast including a plurality of flexible extensions, the plurality of flexible extensions expanding and extending from the distal end of the elongate body when ejected from the distal end of the elongate body, each flexible extension of the plurality of flexible extensions comprising a single length of flexible material that extends between a distal extension end and a proximal extension end, the proximal extension end being coupled to the elongate body, the plurality of flexible extensions configured to radially expand and allow each distal extension end to contact inner walls of a carotid artery when the plurality of flexible extensions are ejected and extending from the distal end of the elongate body;

wherein the plurality of flexible extensions all have distal ends that are disposed distally of the distal end of the elongate body when the plurality of flexible extensions are ejected from the distal end of the elongate body; and

radially expanding the plurality of flexible extensions to thereby enable the distal extension ends of the plurality of flexible extensions to contact an inner wall of a carotid artery and secure a position of the catheter device within a carotid artery.

11 . The method of claim 10 , further comprising:

advancing a distal end of the injector out of the opening and to a target area; and

delivering a fluid from the injector to the target area.

12 . The method of claim 10 , wherein each flexible extension of the plurality of flexible extensions includes a coating, the coating including a rubber material or a silicone material.

13 . The method of claim 11 , wherein the injector includes a fluid pathway for delivering the fluid to a target area.

14 . The method of claim 11 , wherein the fluid includes one or more of an anesthetic, a nerve-blocker, a drug, and a therapeutic.

15 . The method of claim 11 , wherein the target area includes extraluminal space or tissue adjacent a carotid artery.

16 . The method of claim 11 , wherein the injector includes a fluid dispensing feature that controls a direction the fluid is dispensed.

17 . The method of claim 10 , wherein the elongate body includes an outer diameter that is sized to allow the elongate body to travel along a carotid artery.

18 . The method of claim 10 , wherein the elongate body has a length suitable for treatment of a carotid body via a transcervical approach.

19 . The method of claim 18 , wherein the length of the elongate body is within a range of approximately 40 centimeters to 80 centimeters.

20 . A catheter device, comprising:

an elongate body having a distal end and a proximal end;

a passageway extending along a part of the elongate body, the passageway including an opening positioned adjacent the distal end and along an outer wall of the elongate body; and

an injector slidably engaged with the passageway and configured to extend through the opening and penetrate tissue of a carotid artery;

an ejectable holdfast including a plurality of flexible extensions, the plurality of flexible extensions expanding and extending from the distal end of the elongate body when ejected from the distal end of the elongate body, each flexible extension of the plurality of flexible extensions comprising a single length of flexible material that extends between a distal extension end and a proximal extension end, the proximal extension end being coupled to the elongate body, the plurality of flexible extensions radially expand and allow each distal extension end to contact inner walls of a carotid artery when the plurality of flexible extensions are ejected and extending from the distal end of the elongate body;

wherein the plurality of flexible extension includes a first flexible extension having a first distal end;

wherein the plurality of flexible extension includes a second flexible extension having a second distal end;

wherein both the first distal end of the first flexible extension and the second distal end of the second distal extension are disposed distally of the distal end of the elongate body when the first flexible extension and the second flexible extension are ejected from the distal end of the elongate body.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2025
From: SILK ROAD MEDICAL, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 070671/0426 →
RELEASE OF SECURITY INTEREST Recorded Sep 17, 2024
From: OXFORD FINANCE, LLC
To: SILK ROAD MEDICAL, INC.
Reel/Frame 068979/0196 →
SECURITY INTEREST Recorded Jul 11, 2023
From: SILK ROAD MEDICAL, INC.
To: OXFORD FINANCE LLC
Reel/Frame 064252/0197 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2021
From: GARRISON, MICHI E.; RUEDY, RICHARD M.
To: SILK ROAD MEDICAL, INC.
Reel/Frame 057966/0586 →
Continuity (4)
Continuation 16353492 · Mar 14, 2019
Continuation 14078149 · Nov 12, 2013
Provisional Application 61725871 · Nov 13, 2012
Related Publication 20220040502A1 · Feb 10, 2022
References Cited (88)
US 6364876B1 · Erb et al. · 2002 [cited by applicant]
US 6413235B1 · Parodi · 2002 [cited by applicant]
US 6423032B2 · Parodi · 2002 [cited by applicant]
US 6595953B1 · Coppi et al. · 2003 [cited by applicant]
US 6837881B1 · Barbut · 2005 [cited by applicant]
US 7083594B2 · Coppi · 2006 [cited by applicant]
US 7879011B2 · Chang · 2011 [cited by applicant]
US 8150520B2 · Demarais et al. · 2012 [cited by applicant]
US 10272269B2 · Garrison et al. · 2019 [cited by applicant]
US 11097132B2 · Garrison et al. · 2021 [cited by applicant]
US 20050154344A1 · Chang · 2005 [cited by applicant]
US 20050154349A1 · Renz et al. · 2005 [cited by applicant]
US 20060041277A1 · Deem et al. · 2006 [cited by applicant]
US 20060106338A1 · Chang · 2006 [cited by applicant]
US 20060184048A1 · Saadat · 2006 [cited by applicant]
US 20070287886A1 · Saadat · 2007 [cited by applicant]
US 20090024072A1 · Criado et al. · 2009 [cited by applicant]
US 20090198172A1 · Garrison et al. · 2009 [cited by applicant]
US 20090254166A1 · Chou et al. · 2009 [cited by applicant]
US 20100023088A1 · Stack · 2010 [cited by examiner]
US 20100042118A1 · Garrison et al. · 2010 [cited by applicant]
US 20100168731A1 · Wu et al. · 2010 [cited by applicant]
US 20100204684A1 · Garrison et al. · 2010 [cited by applicant]
US 20100217276A1 · Garrison et al. · 2010 [cited by applicant]
US 20100228269A1 · Garrison et al. · 2010 [cited by applicant]
US 20110004147A1 · Renati et al. · 2011 [cited by applicant]
US 20110034986A1 · Chou et al. · 2011 [cited by applicant]
US 20110213459A1 · Garrison et al. · 2011 [cited by applicant]
US 20120232409A1 · Stahmann et al. · 2012 [cited by applicant]
US 20120265198A1 · Crow et al. · 2012 [cited by applicant]
US 20140031925A1 · Garrison et al. · 2014 [cited by applicant]
US 20140046346A1 · Hentges et al. · 2014 [cited by applicant]
US 20140058414A1 · Garrison et al. · 2014 [cited by applicant]
US 20140296769A1 · Hyde et al. · 2014 [cited by applicant]
US 20140296868A1 · Garrison et al. · 2014 [cited by applicant]
US 20150080942A1 · Garrison et al. · 2015 [cited by applicant]
US 20160128688A1 · Garrison et al. · 2016 [cited by applicant]
US 20160158044A1 · Chou et al. · 2016 [cited by applicant]
US 20160166804A1 · Garrison et al. · 2016 [cited by applicant]
US 20160271315A1 · Chang · 2016 [cited by applicant]
US 20160271316A1 · Criado et al. · 2016 [cited by applicant]
US 20170209260A1 · Garrison et al. · 2017 [cited by applicant]
US 20170312491A1 · Ryan et al. · 2017 [cited by applicant]
US 20170361072A1 · Chou et al. · 2017 [cited by applicant]
US 20170368296A1 · Chang · 2017 [cited by applicant]
US 20180008294A1 · Garrison et al. · 2018 [cited by applicant]
US 20180154063A1 · Criado et al. · 2018 [cited by applicant]
US 20180185614A1 · Garrison et al. · 2018 [cited by applicant]
US 20180289884A1 · Criado et al. · 2018 [cited by applicant]
US 20190105439A1 · Criado et al. · 2019 [cited by applicant]
US 20190150916A1 · Hentges et al. · 2019 [cited by applicant]
WO WO2018156574A1 · 2018 [cited by applicant]
WO WO2019010077A1 · 2019 [cited by applicant]
WO WO2019089385A1 · 2019 [cited by applicant]
U.S. Appl. No. 14/227,585, filed Mar. 27, 2014, US 2014-0296769. [cited by applicant]
U.S. Appl. No. 15/049,637, filed Feb. 22, 2016, US 2016-0242764. [cited by applicant]
U.S. Appl. No. 15/399,638, filed Jan. 5, 2017, US 2017-0209260. [cited by applicant]
U.S. Appl. No. 16/281,311, filed Feb. 21, 2019, US 2019-0388654. [cited by applicant]
U.S. Appl. No. 16/299,524, filed Mar. 12, 2019, US 2019-0366070. [cited by applicant]
U.S. Appl. No. 16/377,663, filed Apr. 8, 2019, US 2019-0231962. [cited by applicant]
U.S. Appl. No. 16/513,030, filed Jul. 16, 2019, US 2020-0170637. [cited by applicant]
U.S. Appl. No. 16/530,783, filed Aug. 2, 2019, US 2020-0054871. [cited by applicant]
U.S. Appl. No. 16/544,083, filed Aug. 19, 2019, US 2020-0171277. [cited by applicant]
U.S. Appl. No. 16/880,594, filed May 21, 2020, US 2020-0282127. [cited by applicant]
U.S. Appl. No. 16/894,474, filed Jun. 5, 2020, US 2020-0297912. [cited by applicant]
U.S. Appl. No. 16/906,457, filed Jun. 19, 2020, US 2020-0397472. [cited by applicant]
U.S. Appl. No. 16/939,396, filed Jul. 27, 2020, US 2020-0397446. [cited by applicant]
U.S. Appl. No. 16/951,767, filed Nov. 18, 2020, US 2021-0145453. [cited by applicant]
U.S. Appl. No. 16/999,634, filed Aug. 21, 2020, US 2020-0375728. [cited by applicant]
U.S. Appl. No. 16/999,640, filed Aug. 21, 2020, US 2020-0375729. [cited by applicant]
U.S. Appl. No. 17/000,004, filed Aug. 21, 2020, US 2020-0390438. [cited by applicant]
U.S. Appl. No. 17/074,299, filed Oct. 19, 2020, US 2021-0205571. [cited by applicant]
U.S. Appl. No. 17/092,635, filed Nov. 9, 2020, US 2021-0228847. [cited by applicant]
U.S. Appl. No. 17/108,711, filed Dec. 1, 2020, US 2021-0212679. [cited by applicant]
U.S. Appl. No. 17/149,450, filed Jan. 14, 2021, US 2021-0298929. [cited by applicant]
U.S. Appl. No. 17/179,746, filed Feb. 19, 2021, US 2021-0244522. [cited by applicant]
U.S. Appl. No. 17/193,962, filed Mar. 5, 2021, US 2021-0290257. [cited by applicant]
U.S. Appl. No. 17/206,665, filed Mar. 19, 2021, US 2021-0307945. [cited by applicant]
U.S. Appl. No. 17/220,718, filed Apr. 1, 2021, US 2021-0290213. [cited by applicant]
U.S. Appl. No. 17/237,911, filed Apr. 22, 2021, US 2021-0236790. [cited by applicant]
U.S. Appl. No. 17/307,359, filed May 4, 2021. [cited by applicant]
U.S. Appl. No. 17/308,199, filed May 5, 2021. [cited by applicant]
U.S. Appl. No. 17/345,502, filed Jun. 11, 2021. [cited by applicant]
U.S. Appl. No. 17/345,544, filed Jun. 11, 2021. [cited by applicant]
PCT/US2020/058365, Oct. 30, 2020, WO 2021/087363. [cited by applicant]
PCT/US2020/058588, Nov. 2, 2020, WO 2021/087480. [cited by applicant]
PCT/US2020/061073, Nov. 18, 2020, WO 2021/102011. [cited by applicant]
Henry et al. (1999) “Carotid stenting with cerebral protection: First clinical experience using the PercuSurge GuardWire System” J. Endovasc. Surg. 6:321-331. [cited by applicant]